Stock Analiz

Zepp Health Corp ZEPP

Computer Manufacturing · data as of November 13, 2026

$2.78Market cap $41M
Open the interactive analysis →

Zepp Health Corp (ZEPP) is a technology company listed in the US with a market value of about $41M. In fiscal year 2025 it had revenue of $259M and net income of -$40M, a net margin of -15.5%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).

Key numbers: 5-year revenue growth of -23% a year, a 5-year average ROIC of -6%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 6% above the current price.

About Zepp Health

Zepp Health is listed in the US and classified in computer manufacturing. Revenue went from $138M in 2015 to $259M in 2025, growth of about 6.5% a year. It was profitable in 5 of the last 10 years in our data. It spends 18% of revenue on research and development.

Score: 1.0 / 5

Value1/5
Future growth3/5
Track record0/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.2
P/B0.2
EV/EBITDA—
PEG—
Dividend yield—
FCF yield-64.3%
Shareholder yield3.0%
Intrinsic value vs. price+6%

Growth and quality

Revenue growth (1 yr)41.8%
Revenue growth (5 yrs, per year)-23.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-14.1%
ROIC (5-yr avg.)-6.5%
Profitable years (of last 10)5
Years paying a dividend2

Financials, last 10 years

Fiscal year2025202420232022202120202019201820172016
Revenue$259M$183M$351M$614M$984M$984M$835M$530M$315M$224M
Net income-$40M-$76M-$31M-$43M$22M$35M$83M$49M$26M—
Free cash flow-$26M-$26M$41M-$118M-$44M$11M$57M$100M$33M—
EPS (diluted)$-2.73$-5.16$-2.12$-2.95$1.47$2.39$5.63$3.37$1.76—
Net margin-15.5%-41.5%-8.8%-7.0%2.2%3.6%9.9%9.3%8.2%—
ROIC-7.0%-11.3%-5.9%-10.4%2.3%5.3%20.7%17.3%67.4%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Zepp Health stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 6% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Zepp Health pay a dividend?

Not currently.

Is Zepp Health a good stock to buy?

We do not give buy or sell advice. Zepp Health scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.